The federal contract IDV award SPE2D220D0088 is an Indefinite Delivery Contract awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Puracap Laboratories LLC, doing business as BLU Pharmaceuticals. The contract has a ceiling value of $1,020,032.00 and a period of performance through April 20, 2025. The purpose of this IDC is to establish a national supply source for the procurement of Azithromycin Suspension 200MG/5ML 15ML and 200MG/5MG 30ML bottles by the...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 single-award IDC, under the SPE2DB program, runs through December 31, 2025 and allows DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. The IDC covers a vast array...
The Indefinite Delivery Contract (IDC) SPE2DU25D9423 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,999,999 single-award IDC enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health...
The Indefinite Delivery Contract (IDC) SPE2DR25D9637 was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,999,999.00, is for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers worldwide. This IDC is part of the DLA's...
This Indefinite Delivery Contract (IDC) is a single-award vehicle awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide pharmaceutical and medical supply support to various Department of Defense (DoD) customers, including the Defense Health Agency, US Coast Guard, and US Naval Fleet. The IDC is valued at $499,999,999 and has a period of performance through November 2026. It enables DLA to issue firm fixed-price delivery orders...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Golden State Medical Supply, Inc., a for-profit manufacturer and distributor of pharmaceutical products. The $9.7 million single-award IDC (contract number SPE2D220D0091) has an ultimate completion date of April 28, 2025. The contract enables the Department of Defense (DoD), Department of Veterans Affairs (VA), Bureau of Prisons, and Indian Health Service (IHS) to place delivery orders against...
This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 single-award IDC, valid through November 30, 2026, covers a comprehensive range of pharmaceutical products and medical supplies to fulfill the recurring medical needs of military health facilities worldwide under the SPE2DB program. The contract scope includes branded...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Golden State Medical Supply, Inc. (GSMS), a for-profit manufacturer and distributor of pharmaceuticals and other medical products. The contract has a ceiling value of $4,547,341.50 and a period of performance ending on May 23, 2026. The IDC facilitates the provision of a wide range of pharmaceutical products to the Department of Defense (DoD), Department of Veterans Affairs (VA),...
The Indefinite Delivery Contract (IDC) SPE2DR25D1041 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,999,999,999 IDC has a period of performance from August 1, 2025 to December 31, 2036, and supports DLA, the Department of Defense (DoD), the U.S. Coast Guard, and other government agencies by providing a comprehensive range of pharmaceutical products...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The single-award IDC, valued at up to $499,999,999, covers a comprehensive range of pharmaceutical products to fulfill the recurring medical supply needs of military health facilities worldwide under the SPE2DB program. The contract includes a vast array of pharmaceutical items, from common medications to specialized...